|
1
|
Yusuf S, Reddy S, Ounpuu S and Anand S:
Global burden of cardiovascular diseases: Part I: General
considerations, the epidemiologic transition, risk factors, and
impact of urbanization. Circulation. 104:2746–2753. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Heart disease and stroke statistics-2014 update: A report from the
American Heart Association. Circulation. 129:e28–e292. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Falk E: Pathogenesis of atherosclerosis. J
Am Coll Cardiol. 47:(8 Suppl). C7–C12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cruzado JM: Nonimmunosuppressive effects
of mammalian target of rapamycin inhibitors. Transplant Rev
(Orlando). 22:73–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Z and Ming XF: mTOR signalling: The
molecular interface connecting metabolic stress, aging and
cardiovascular diseases. Obes Rev. 13:(Suppl 2). S58–S68. 2012.
View Article : Google Scholar
|
|
6
|
Yang Q and Guan KL: Expanding mTOR
signaling. Cell Res. 17:666–681. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sciarretta S, Volpe M and Sadoshima J:
Mammalian target of rapamycin signaling in cardiac physiology and
disease. Circ Res. 114:549–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martinet W, De Loof H and De Meyer GR:
mTOR inhibition: A promising strategy for stabilization of
atherosclerotic plaques. Atherosclerosis. 233:601–607. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johnson SC, Rabinovitch PS and Kaeberlein
M: mTOR is a key modulator of ageing and age-related disease.
Nature. 493:338–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mueller MA, Beutner F, Teupser D, Ceglarek
U and Thiery J: Prevention of atherosclerosis by the mTOR inhibitor
everolimus in LDLR−/− mice despite severe
hypercholesterolemia. Atherosclerosis. 198:39–48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen WQ, Zhong L, Zhang L, Ji XP, Zhang M,
Zhao YX, Zhang C and Zhang Y: Oral rapamycin attenuates
inflammation and enhances stability of atherosclerotic plaques in
rabbits independent of serum lipid levels. Br J Pharmacol.
156:941–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma KL, Ruan XZ, Powis SH, Moorhead JF and
Varghese Z: Anti-atherosclerotic effects of sirolimus on human
vascular smooth muscle cells. Am J Physiol Heart Circ Physiol.
292:H2721–H2728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mathis AS, Jin S, Friedman GS, Peng F,
Carl SM and Knipp GT: The pharmacodynamic effects of sirolimus and
sirolimus-calcineurin inhibitor combinations on macrophage
scavenger and nuclear hormone receptors. J Pharm Sci. 96:209–222.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu M, Kang X, Xue H and Yin H: Toll-like
receptor 4 is up-regulated by mTOR activation during THP-1
macrophage foam cells formation. Acta Biochim Biophys Sin
(Shanghai). 43:940–947. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomson AW, Turnquist HR and Raimondi G:
Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol.
9:324–337. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sordi V, Bianchi G, Buracchi C, Mercalli
A, Marchesi F, D'Amico G, Yang CH, Luini W, Vecchi A, Mantovani A,
et al: Differential effects of immunosuppressive drugs on chemokine
receptor CCR7 in human monocyte-derived dendritic cells: Selective
upregulation by rapamycin. Transplantation. 82:826–834. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Trogan E, Feig JE, Dogan S, Rothblat GH,
Angeli V, Tacke F, Randolph GJ and Fisher EA: Gene expression
changes in foam cells and the role of chemokine receptor CCR7
during atherosclerosis regression in ApoE-deficient mice. Proc Natl
Acad Sci USA. 103:3781–3786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feig JE, Pineda-Torra I, Sanson M, Bradley
MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C,
Liu J, et al: LXR promotes the maximal egress of monocyte-derived
cells from mouse aortic plaques during atherosclerosis regression.
J Clin Invest. 120:4415–4424. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baker RG, Hayden MS and Ghosh S: NF-κB,
inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takeda-Watanabe A, Kitada M, Kanasaki K
and Koya D: SIRT1 inactivation induces inflammation through the
dysregulation of autophagy in human THP-1 cells. Biochem Biophys
Res Commun. 427:191–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng HT, Fu YC, Yu W, Lin JM, Zhou L, Liu
L and Wang W: SIRT1 prevents atherosclerosis via liver-X-receptor
and NF-κB signaling in a U937 cell model. Mol Med Rep. 8:23–28.
2013.PubMed/NCBI
|
|
22
|
Zhang S, Cai G, Fu B, Feng Z, Ding R, Bai
X, Liu W, Zhuo L, Sun L, Liu F and Chen X: SIRT1 is required for
the effects of rapamycin on high glucose-inducing mesangial cells
senescence. Mech Ageing Dev. 133:387–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Medvedik O, Lamming DW, Kim KD and
Sinclair DA: MSN2 and MSN4 link calorie restriction and TOR to
sirtuin-mediated lifespan extension in saccharomyces cerevisiae.
PLoS Biol. 5:e2612007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghosh HS, McBurney M and Robbins PD: SIRT1
negatively regulates the mammalian target of rapamycin. PLoS One.
5:e91992010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cui MZ: Lysophosphatidic acid effects on
atherosclerosis and thrombosis. Clin Lipidol. 6:413–426. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lamming DW and Sabatini DM: A Central role
for mTOR in lipid homeostasis. Cell Metab. 18:465–469. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu
Y, Lv LL, Ruan XZ and Liu BC: Activation of mTOR modulates SREBP-2
to induce foam cell formation through increased retinoblastoma
protein phosphorylation. Cardiovasc Res. 100:450–460. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fueller M, Wang DA, Tigyi G and Siess W:
Activation of human monocytic cells by lysophosphatidic acid and
sphingosine-1-phosphate. Cell Signal. 15:367–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bot M, Bot I, Lopez-Vales R, van de Lest
CH, Saulnier-Blache JS, Helms JB, David S, van Berkel TJ and
Biessen EA: Atherosclerotic lesion progression changes
lysophosphatidic acid homeostasis to favor its accumulation. Am J
Pathol. 176:3073–3084. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghosh HS, McBurney M and Robbins PD: SIRT1
negatively regulates the mammalian target of rapamycin. PLoS One.
5:e91992010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu J, Dang Y, Ren YR and Liu JO:
Cholesterol trafficking is required for mTOR activation in
endothelial cells. Proc Natl Acad Sci USA. 107:4764–4769. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gareus R, Kotsaki E, Xanthoulea S, van der
Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de
Winther MP and Pasparakis M: Endothelial cell-specific NF-κB
inhibition protects mice from atherosclerosis. Cell Metab.
8:372–383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma KL, Ruan XZ, Powis SH, Chen Y, Moorhead
JF and Varghese Z: Inflammatory stress exacerbates lipid
accumulation in hepatic cells and fatty livers of apolipoprotein E
knockout mice. Hepatology. 48:770–781. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yeung F, Hoberg JE, Ramsey CS, Keller MD,
Jones DR, Frye RA and Mayo MW: Modulation of NF-κB-dependent
transcription and cell survival by the SIRT1 deacetylase. EMBO J.
23:2369–2380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salminen A, Kauppinen A, Suuronen T and
Kaarniranta K: SIRT1 longevity factor suppresses NF-κB-driven
immune responses: Regulation of aging via NF-kappaB acetylation?
Bioessays. 30:939–942. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cohen HY, Miller C, Bitterman KJ, Wall NR,
Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R and Sinclair
DA: Calorie restriction promotes mammalian cell survival by
inducing the SIRT1 deacetylase. Sci. 305:390–392. 2004. View Article : Google Scholar
|
|
37
|
Blagosklonny MV: Calorie restriction:
decelerating mTOR-driven aging from cells to organisms (including
humans). Cell Cycle. 9:683–688. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma L, Dong W, Wang R, Li Y, Xu B, Zhang J,
Zhao Z and Wang Y: Effect of caloric restriction on the SIRT1/mTOR
signaling pathways in senile mice. Brain Res Bull. 116:67–72. 2015.
View Article : Google Scholar : PubMed/NCBI
|
